Alizin 30 mg/ml Solution for Injection
Alizin 30 mg/ml Solution for Injection
Authorised
- Aglepristone
Product identification
Medicine name:
Alizin 30 mg/ml Solution for Injection
Alizin 30 mg/ml Oplossing voor injectie
Alizin 30 mg/ml Solution injectable
Alizin 30 mg/ml Injektionslösung
Active substance:
- Aglepristone
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Aglepristone30.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03XB90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Vial (glass, type II) of 5 ml for injectable preparation, with bromobutyl stopper and aluminum cap.Presentation:- box of 1 vial of 5ml
- Vial (glass, type II) of 10 ml for injectable preparation, with bromobutyl stopper and aluminum cap.Presentation:- box of 1 vial of 10ml.
- Vial (glass, type II) of 30 ml for injectable preparation, with bromobutyl stopper and aluminum cap.Presentation:- box of 1 vial of 30ml.
- Vials (glass, type II) of 10 ml for injectable preparations, with bromobutyl stoppers and aluminum caps.Presentation:- box of 10 vials of 10ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V263986
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0500/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 16/11/2025